Anemia
| Anemia | |
|---|---|
| Other names | Anaemia, erythrocytopenia |
| Blood smear showing iron-deficiency anemia, with small, pale red blood cells | |
| Pronunciation | |
| Specialty | Hematology |
| Symptoms | Feeling tired, pale skin, weakness, shortness of breath, feeling faint[1] |
| Causes | Blood loss, decreased red blood cell production, increased red blood cell breakdown[1] |
| Diagnostic method | Blood hemoglobin measurement[1] |
| Frequency | 1.92 billion / 24% (2021)[2] |
Anemia (also spelt anaemia in British English) is a blood disorder in which the blood has a reduced ability to carry oxygen. This can be due to a lower than normal number of red blood cells, a reduction in the amount of hemoglobin available for oxygen transport, or abnormalities in hemoglobin that impair its function.[3][4]
When anemia comes on slowly, the symptoms are often vague, such as tiredness, weakness, shortness of breath, headaches, and a reduced ability to exercise.[1] When anemia is acute, symptoms may include confusion, feeling like one is going to pass out, loss of consciousness, and increased thirst.[1] Anemia must be significant before a person becomes noticeably pale.[1] Additional symptoms may occur depending on the underlying cause.[1] Anemia can be temporary or long-term and can range from mild to severe.[5]
Anemia can be caused by blood loss, decreased red blood cell production, and increased red blood cell breakdown.[1] Causes of blood loss include menstruation, bleeding due to inflammation of the stomach or intestines, bleeding from surgery, serious injury, or blood donation.[1] Causes of decreased production include iron deficiency, folate deficiency, vitamin B12 deficiency, thalassemia and a number of bone marrow tumors.[1] Causes of increased breakdown include genetic disorders such as sickle cell anemia, infections such as malaria, and certain autoimmune diseases like autoimmune hemolytic anemia.[1]
Anemia can also be classified based on the size of the red blood cells and amount of hemoglobin in each cell.[1] If the cells are small, it is called microcytic anemia; if they are large, it is called macrocytic anemia; and if they are normal sized, it is called normocytic anemia.[1] The diagnosis of anemia in men is based on a hemoglobin of less than 130 g/L; in non-pregnant women, it is less than 120 g/L, while in pregnant women it is less than 105–110.[6][7] Further testing is then required to determine the cause.[1][8]
Treatment depends on the specific cause. Certain groups of individuals, such as pregnant women, can benefit from the use of iron pills for prevention.[1][9] Dietary supplementation, without determining the specific cause, is not recommended.[1] The use of blood transfusions is typically based on a person's signs and symptoms.[1] In those without symptoms, they are not recommended unless hemoglobin levels are less than 60 to 80 g/L (6 to 8 g/dL).[1][10] These recommendations may also apply to some people with acute bleeding.[1] Erythropoiesis-stimulating agents are only recommended in those with severe anemia.[10]
Anemia is the most common blood disorder, affecting about a fifth to a third of the global population.[1][11][12] Iron-deficiency anemia is the most common cause of anemia worldwide, and affects nearly one billion people.[13] In 2013, anemia due to iron deficiency resulted in about 183,000 deaths – down from 213,000 deaths in 1990.[14] This condition is most prevalent in children[15][16] with also an above average prevalence in elderly[1] and women of reproductive age (especially during pregnancy).[13] Women aged 15 to 49 years experienced an increase in the global prevalence from 27.6% to 30.7% between 2012 to 2023 with either no improvement or an increase in prevalence in nearly all regions.[17] Anemia is one of the six WHO global nutrition targets for 2025 and for diet-related global targets endorsed by World Health Assembly in 2012 and 2013. Efforts to reach global targets contribute to reaching Sustainable Development Goals (SDGs),[18] with anemia as one of the targets in SDG 2 for achieving zero world hunger.[19]
Signs and symptoms
[edit]
Symptoms of anemia can come on quickly or slowly.[21] If the anemia develops slowly (chronic), the body may adapt and compensate for this change up to a point. In this case, no symptoms may appear until the anemia becomes more severe.[20][22] General symptoms of mild anemia can include feeling tired, weak, dizziness, headaches, shortness of breath, and pale or yellowish skin.[22][23]
Acute anemia, often caused by blood loss (hemorrhagic shock) has more severe symptoms, including rapid heartbeat, low blood pressure,and confusion.[24]
The body may compensate for the lack of oxygen-carrying capability of the blood by increasing cardiac output. Symptoms related to this may include palpitations, angina (if pre-existing heart disease is present), difficulty walking, and symptoms of heart failure.[25] In severe anemia, there may be signs of a hyperdynamic circulation: tachycardia (a fast heart rate), bounding pulse, flow murmurs, and cardiac ventricular hypertrophy (enlargement).[24]
Chronic anemia in infants may result in poor growth and impaired neurological development.[26]
Pallor resulting from severe anemia may be visible in the hand palms and fingernails beds, although it may be difficult to detect in dark toned skin. Other locations to detect pallor are the inner lining of the lower eyelid and the tongue.[27][28][29]
Other symptoms associated with anemia depend on the underlying cause of the disorder; for example -
- Chronic iron-deficiency anemia may be associated with symptoms that can include spoon-shaped nails, sore or abnormally smooth tongue, hair loss, or pica (the desire to eat things which are not food, such as ice or earth).[30]
- Anemia caused by vitamin B12 deficiency may be associated with psychological problems such as anxiety and confusion, memory loss, and depression.[31]
Diagnosis
[edit]

Definitions
[edit]There are several definitions of anemia.[32] A strict but broad definition is an absolute decrease in red blood cell mass,[33] however, a broader definition is a lowered ability of the blood to carry oxygen.[34] An operational definition is a decrease in whole-blood hemoglobin concentration of more than 2 standard deviations below the mean of an age- and sex-matched reference range.[35]
| Age or gender group | Hb threshold (g/L) |
|---|---|
| Children (0.5–2 yrs) | 105 |
| Children (2–5 yrs) | 110 |
| Children (5–12 yrs) | 115 |
| Teens (12–15 yrs) | 120 |
| Non-pregnant women (>15yrs) | 120 |
| Pregnant girls and women | 105–110 |
| Men (>15yrs) | 130 |
Etymology
[edit]The name is derived from Ancient Greek ἀν- (an-) 'not' and "αἷμᾰ" (haîmă) 'blood'.[37] A related word, ischemia, derives from the Greek from ῐ̓́σχω (ĭ́skhō, "stop") and αἷμᾰ (haîmă, "blood"); the roots of the both words refer to the basic idea of "lack of blood", but the meaning is significantly different. Anemia implies widespread effects from blood that either is too scarce (e.g., blood loss) or is dysfunctional in its oxygen-supplying ability (due to whatever type of hemoglobin or erythrocyte problem). Ischemia is a restriction in blood supply to any tissue, muscle, or organ of the body, causing a shortage of oxygen that is needed to keep tissues alive, as may occur for example in a stroke.[38][39][40]
Testing
[edit]Anemia is typically diagnosed on a complete blood count from a blood sample. An automated hematology analyzer measures the hemoglobin level, hematocrit (% volume of RBCs in the blood), the size of the RBCs,[41] and counts of white blood cells and platelets.
Further tests will be needed to determine the underlying cause; these may include (not a complete list):[42][43]
- A count of reticulocytes (immature RBCs), which measures the capacity of the bone marrow to produce new RBCs.[44]
- Iron profile, to establish if there is underlying iron deficiency (the most common cause of anemia).[45]
- Family history and genetic testing, to establish if there is an inherited disorder (the second most common cause).[45]
- Peripheral blood smear - a small blood sample is examined under a microscope to check the size and shape of RBCs. Among other things, this should detect malaria parasites, which are globally the third most common cause.[46][47]
- Serum creatinine, to check if poor kidney function underlies the anemia.[48]
Causes
[edit]
In humans, mature red blood cells (RBCs) are flexible biconcave disks, lacking cell nucleus and organelles. The process by which new RBCs are produced is termed erythropoiesis; committed stem cells in the red bone marrow of large bones take 7 days to mature into red blood cells. Between 2 and 3 million new RBCs are produced per second in human adults.[50] The functional lifetime of a RBC is about 100–120 days, during which time the cells are continually moving within the blood circulation.[51] The aging RBC undergoes changes in its plasma membrane, making it susceptible to recognition by macrophages and subsequent breakdown in the spleen, thus removing old and defective cells and continually purging the blood.[52] This process is termed eryptosis; much of the resulting breakdown products are recirculated in the body.[53] RBC breakdown by eryptosis normally occurs at the same rate as production by erythropoiesis, thus maintaining a balanced RBC population in the circulation.[54]
The causes of anemia may be classified as impaired red blood cell (RBC) production, increased RBC destruction (hemolytic anemia), blood loss, and fluid overload (hypervolemia).[55] Globally, the most common underlying cause of anemia is dietary iron deficiency, followed by the inherited conditions thalassaemia and sickle cell trait, and infectious disease (principally malaria).[28]
Impaired production
[edit]- Disturbance of proliferation and differentiation of stem cells
- Pure red cell aplasia[56]
- Aplastic anemia[56] affects all kinds of blood cells. Fanconi anemia is a hereditary disorder or defect featuring aplastic anemia and various other abnormalities, including malformation of the extremities.[57]
- Anemia of kidney failure[56] due to insufficient production of the hormone erythropoietin
- Anemia of endocrine disease[58]
- Disturbance of proliferation and maturation of erythroblasts
- Pernicious anemia is a form of megaloblastic anemia due to vitamin B12 deficiency.[56]
- Anemia of folate deficiency, as with vitamin B12, causes megaloblastic anemia.[56]
- Anemia of prematurity, by diminished erythropoietin response to declining hematocrit levels, combined with blood loss from laboratory testing, generally occurs in premature infants at two to six weeks of age.[59]
- Iron-deficiency anemia, resulting in deficient heme synthesis.[56] Globally, this is the most common type of anemia; it may be caused by poor diet (common in poor communities),[60] blood loss, or poor absorption of iron from food.[61] Sources of blood loss can include heavy periods, childbirth, uterine fibroids, stomach ulcers, colon cancer, and urinary tract bleeding.[62] Poor absorption of iron from food may occur as a result of an intestinal disorder such as inflammatory bowel disease or celiac disease, or surgery such as a gastric bypass.[62] In low income communities with poor diet, parasitic worms, malaria, and HIV/AIDS increase the risk of iron deficiency anemia.[60]
- Thalassemias, causing deficient globin synthesis[56]
- Congenital dyserythropoietic anemias, causing ineffective erythropoiesis.[63]
- Anemia of kidney failure.[56]
- Other mechanisms of impaired RBC production
- Myelophthisic anemia or myelophthisis is a severe type of anemia resulting from the replacement of bone marrow by other materials, such as malignant tumors, fibrosis, or granulomas.[56] The term Leukoerythroblastic is applied to a typical blood smear showing immature and abnormal erythrocytes.[64]
- Myelodysplastic syndrome[56]
- Anemia of chronic disease.
- Chronic inflammation can disrupt iron handling, limiting its availability for red blood cell formation.[56] In chronic inflammation, the liver produces high levels of hepcidin, a hormone which regulates iron metabolism.[65] This leads to high ferritin levels and low transferrin saturation, a pattern known as "functional iron deficiency." In this condition, iron availability is restricted even when total body iron stores are adequate, contributing to anemia common in inflammatory bowel diseases and chronic infections.[66] This mechanism is commonly seen in older hospitalized patients with long-standing illnesses such as infections, heart failure or autoimmune conditions.[67]
- Intestinal inflammation, which may be caused by: Helicobacter pylori infection.[68], gluten-related disorders such as untreated celiac disease[69][68] and non-celiac gluten sensitivity;[70] or Inflammatory bowel disease.[71][72]
Increased destruction
[edit]Anemias of increased red blood cell destruction are generally classified as hemolytic anemias. These types generally feature jaundice, and elevated levels of lactate dehydrogenase.[73][74]
- Intrinsic (intracorpuscular) abnormalities[56] cause premature destruction. All of these, except paroxysmal nocturnal hemoglobinuria, are hereditary genetic disorders.[75]
- Hereditary spherocytosis[56] is a hereditary defect that results in defects in the RBC cell membrane, causing the erythrocytes to be sequestered and destroyed by the spleen.[76]
- Hereditary elliptocytosis[56] is another defect in membrane skeleton proteins.
- Abetalipoproteinemia,[56] causing defects in membrane lipids.[77]
- Enzyme deficiencies
- Pyruvate kinase and hexokinase deficiencies,[56] causing defect glycolysis.[78]
- Glucose-6-phosphate dehydrogenase deficiency (G6PDD) and glutathione synthetase deficiency,[56] causing increased oxidative stress.[79]
- Hemoglobinopathies
- Sickle cell anemia[56]
- Hemoglobinopathies causing unstable hemoglobins[56]
- Paroxysmal nocturnal hemoglobinuria[56]
- Extrinsic (extracorpuscular) abnormalities
- Antibody-mediated
- Warm autoimmune hemolytic anemia is caused by an autoimmune attack against red blood cells, primarily by IgG. It is the most common of the autoimmune hemolytic diseases.[80] It can be idiopathic, that is, without any known cause, drug-associated or secondary to another disease such as systemic lupus erythematosus, or a malignancy, such as chronic lymphocytic leukemia.[81]
- Cold agglutinin hemolytic anemia is primarily mediated by IgM. It can be idiopathic or result from an underlying condition.[82]
- Rh disease,[56] one of the causes of hemolytic disease of the newborn
- Transfusion reaction to blood transfusions[56]
- Mechanical trauma to red blood cells
- Parasitic
- Trypanosoma congolense causes the disease nagana in cattle and other domesticated animals.[85]
- Infection with the malaria parasite is a common cause of anemia across many tropical and subtropical regions.[56]
- Breakdown of hemoglobin
- Heinz body anemia, which may be caused by G6PD deficiency, or through oxidative damage by administered drugs.[86]
- Antibody-mediated
Blood loss
[edit]- Trauma[56]
- Gastrointestinal blood loss:
- Lesions, leading to either acute bleeds (e.g. variceal lesions, peptic ulcers, hemorrhoids[87]) or chronic blood loss (e.g. angiodysplasia).[56]
- Chronic bleeding due to infection by intestinal nematodes feeding on blood, such as hookworms[88][66] and the whipworm Trichuris trichiura [89]
- Gynecologic disturbances:[56]
- From abnormally heavy menstruation[90]
- Repeated pregnancies and short birth intervals.[66]
- Many types of cancers, such as leukemia and multiple myeloma, may cause acute or chronic blood loss.[91]
- Anemia caused by medical interventions (Iatrogenic anemia): acute blood loss blood loss from repeated blood draws, surgical procedures, or as a side effect of chemotherapy.[92][93][91]
Fluid overload
[edit]Fluid overload (hypervolemia) causes decreased hemoglobin concentration and apparent anemia:[94]
- General causes of hypervolemia include excessive sodium or fluid intake, sodium or water retention.[95]
- During early pregnancy, hormonal changes trigger an increase in blood plasma volume, while red cell mass increases more slowly. This physiological change dilutes existing RBCs and may trigger a diagnosis of anemia.[66][96]
General global contributors
[edit]- In many regions, nutritional deficiencies are major drivers of reduced RBC production. Poor intake of iron, folate, and vitamin B12 can significantly impair hemoglobin synthesis and erythropoiesis. This is especially common in low-income populations, areas with limited food diversity, and communities experiencing famine.[66] Socioeconomic factors such as poverty, limited access to nutrient-rich foods, and high rates of parasitic exposure increase the risk of iron-deficiency anemia in women and children.[66]
- Pregnancy greatly increases iron requirements, and inadequate dietary intake during pregnancy is one of the leading causes of anemia among reproductive-age women worldwide.[66]
- Chronic infections common in developing countries, such as malaria and hookworm disease, impair erythropoiesis either through inflammatory suppression or recurrent blood loss leading to iron depletion.[66]
Classification systems
[edit]Anemia is often classified by the size of red blood cells, visible in a peripheral blood smear. The mean corpuscular volume (MCV) of a normal RBC is between 80 and 100 femtoliters. If the cells are smaller than 80 fl, the anemia is said to be microcytic; if they are larger than 100 fl, the anemia is macrocytic. Within the normal range, the anemia is normocytic.[97]
The most common causes of microcytic anemia are iron deficiency, thalassemia, and chronic diseases such as autoimmunity or cancer.[97][98] Macrocytic anemia can be caused by e.g. vitamin deficiency (B12 or folate), alcohol use disorder, or hypothyroidism.[97] Normocytic anemias include those caused by blood loss, some chronic diseases, or kidney disease.[97][99]
The other principal principle method of classification looks at the balance between erythropoiesis (RBC production in the bone marrow) and eryptosis (RBC breakdown, principally in the spleen). Anemias in which the bone marrow fails to make sufficient RBCs are termed hypoproliferative; included in this group are nutrient deficiencies (e.g. iron, B12, folate), thalassemia, and cancers which affect the bone marrow.[97] When production is normal but there is excessively rapid breakdown of RBCs, the term is hemolytic anemia. This group includes sickle cell anemia, malaria, glucose-6-phosphate dehydrogenase deficiency and some autoimmune conditions such as lupus.[100][101] Acute anemia caused by blood loss - e.g. following injury, surgery or childbirth - doesn't fit into this classification.[102]
Transfusion dependence
[edit]Anemia is classified as transfusion-dependent if regular blood transfusions are required to maintain quality of life, or to prevent death.[103] Most people with myelodysplastic syndrome develop this state at some point in time.[104] Beta thalassemia may also result in transfusion dependence.[105][106] Concerns from repeated blood transfusions include iron overload,[104] which may require chelation therapy.[107]
Treatment
[edit]Cause
[edit]Treatment of anemia depends entirely on establishing the underlying cause.[108]
Acute anemia
[edit]Acute anemia is typically caused by sudden loss of blood, e.g. through injury, hemorrhage, or breakdown of red blood cells as in malaria or some conditions causing acute hemolysis. This can be relieved with supplemental oxygen or blood transfusion. Provided the root cause can be fixed, these treatments can be discontinued as recovery takes place and the body naturally replaces the lost blood cells.[109]
Deficiency anemias
[edit]The most common cause of anemia is iron deficiency, and the most common cause of this is poor diet, especially in low income communities. Other common deficiencies causing anemia are vitamin B12 and folate. Treatment for these involves supplements - iron or B12 (either as tablet or injection) or folate (as tablet).[110] Changes to diet will be recommended if poor diet is causing or contributing to the anemia.[110] Other contributing factors - e.g. intestinal disease affecting the absorption of nutrients, or hookworm infection - must also be treated.[111][112] For women with severe menstrual bleeding which leads to iron deficiency, hormone treatment may be effective.[111]
Hereditary anemias
[edit]The most common hereditary causes of anemia are sickle-cell disease (causing increased hemolysis) and thalassemia (reduced production of hemoglobin).[113] Less common are hereditary spherocytosis and G6PD Deficiency.[114][115] Generally speaking, mild cases can cause few symptoms and either need no treatment or can be managed by means of avoiding circumstances which might trigger a crisis, monitoring and occasional treatment. More severe cases may need be treated by blood transfusion or surgical removal of the spleen.[113] Sickle-cell disease and thalassemia may also be treated by means of stem cell transplantation.[116]
Iatrogenic anemias
[edit]Iatrogenic anemias are caused by medical interventions.[117] Most common is repeated blood draws, e.g. while in hospital critical care. This can be mitigated by minimising the frequency or volume of blood taken, and by blood transfusion.[118] Some forms of chemotherapy can cause anemia; if the regimen cannot be changed, transfusions are necessary.[119]
Principal methods of treatment
[edit]Iron supplementation
[edit]Iron deficiency results in the decreased production of hemoglobin, the oxygen-carrying protein in red blood cells.[120] Mild to moderate iron-deficiency anemia is treated by iron supplementation in the diet.[120] In cases where this is either ineffective, would be too slow (for example, pre-operatively), or where absorption is impeded (for example, in cases of inflammation), iron supplementation can be given intravenously.[120]
Blood transfusions
[edit]
Blood transfusion is the process of transferring blood products into a person's circulation intravenously.[121] Transfusion is generally recommended if hemoglobin falls below 70 to 80 grams/liter.[122][needs update] Prior to transfusion, the donated blood is carefully crossmatched with the patient's blood to ensure compatibility. During transfusion, the patient is monitored for any side effects.[123]
Bone marrow transplant
[edit]
Red blood cells are manufactured in the bone marrow. A bone marrow transplant may be recommended if the marrow is unable to produce enough red blood cells, as for example in aplastic anemia.[124] In a bone marrow transplant, old defective bone marrow is destroyed using drugs and replaced with new stem cells from a compatible donor.[123]
Vitamin B12
[edit]In severe cases where vitamin B12 diet is not being absorbed in the intestine, it can instead be supplemented via intramuscular injection. Pernicious anemia, for example, is a type of vitamin B12 deficiency anemia that results from lack of intrinsic factor.[125] Vitamin B12 injections, initially given daily, are quick-acting, and symptoms usually go away within one to two weeks.[126] As the condition improves, doses are reduced in frequency. In some cases lifelong treatment may be needed.[127]
Erythropoiesis-stimulating agents
[edit]Erythropoiesis-stimulating agents (ESA) work to increase production of erythropoietin, a hormone that increases the production of red blood cells.[128] They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.[129][130] In these situations they decrease the need for blood transfusions.[130]
Epidemiology
[edit]Anemia affects 24% of the world's population, with iron-deficiency anemia accounting for the majority of cases.[131]
Geographical trends
[edit]Globally, anemia is most common in the tropical areas of sub-Saharan Africa and South Asia. As of 2021[update], anemia affected 47.4% of the population in Western sub-Saharan Africa and 35.7% in South Asia.[132] This is due to a combination of combination of poor diet (contributing to iron deficiency), parasitic diseases, and hemoglobinopathies such as sickle cell disease. Women of reproductive age are more at risk due to blood loss during menstruation or childbirth.[132]
Population groups at higher risk
[edit]Generally speaking, the very young and the very old have a higher risk of anemia than the general population. In the first few months after birth, babies have a natural dip in hemoglobin levels (physiologic anemia) as their body adjusts to life outside the womb;[133] this can be aggravated by other factors such as premature birth, blood loss, and consumption of cow's milk.[134] As children grow, they have a proportionately higher need for iron in their diet compared with adults, and are at risk of anemia if they have a poor diet.[135]
Women of reproductive age have enhanced risk of anemia.[136] This could be associated with loss of blood during menstruation, or with pregnancy. In normal pregnancies, a natural increase in plasma volume is not matched by an increase in RBC mass leading to a mild decrease in hemoglobin concentration referred to as physiologic (or dilutional) anemia.[137] There is also a risk of blood loss during childbirth.[138]
The major inherited anemias, thalassemia and sickle cell, are prevalent in areas which are historically prone to malaria - Africa, the Mediterranean, the Middle East, and South Asia. They are now more widely distributed geographically among populations who originated in the areas; this is a consequence of the slave trade in the 18th and 19th centuries, and other causes of migration more recently.[139][140]
Socioeconomic status
[edit]Deficiency anemias (iron, B12 or folate deficiency) are strongly linked with low socioeconomic status. This is attributed to a combination of poor diet and poor health literacy. This translates geographically into a high incidence of these anemias in low and middle-income countries. Low income groups in developed countries also show an increased incidence of anemia.[141][142][143][144]
History
[edit]Signs of severe anemia in human bones from 4000 years ago have been uncovered in Thailand.[145]
The first discovery and discussion of blood was in 1674 when Antoni van Leeuwenhoek described red blood cells (RBCs) as "small round globules." RBCs counterpart, hemoglobin, wasn't discovered until much later by FL Hünefeld in 1840. In 1746, Vincenzo Menghini showed that iron was concentrated in the red blood cells using a magnetic knife.[146] Between 1877-1885, many key tools emerged like hemocytometer (RBC count), hemoglobin measurement, and hematocrit measurement that allowed for quantitative diagnosis of blood.[147] By the 1920s it was confirmed by multiple different studies that iron existed in plasma. McCance and Widdowson showed that iron is not excreted from the body in 1938, and it was later confirmed that iron absorption is the main way the body regulates iron levels.[citation needed]
In ancient cultures, like Assyria and Mediterranean societies, used iron for medical treatments, however, this occurred before iron's biological role was understood. In the 1500s, Nicholas Monarde used iron's "healing powers" to treat gout, acne and hair loss.[146] Anemia started out as a clinical entity in 1807. Early diagnosis of anemia in the early 1800s were based solely on physical examinations such as fatigue, paleness, sweating, difficulty breathing, and dizziness. It wasn't until late in the 1800s when new technologies allowed for a more in depth, lab-based diagnosis on anemia.[148] In 1939, anemia was officially defined as "a deficiency of blood not due to hemorrhage".[147]
References
[edit]- ^ a b c d e f g h i j k l m n o p q r s t u Janz TG, Johnson RL, Rubenstein SD (November 2013). "Anemia in the emergency department: evaluation and treatment". Emergency Medicine Practice. 15 (11): 1–15, quiz 15–16. PMID 24716235.
- ^ Gardner WM, et al. (2023). "Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021". The Lancet Haematology. 10 (9): e713–e734. doi:10.1016/s2352-3026(23)00160-6. hdl:2164/22615. ISSN 2352-3026. PMC 10465717. PMID 37536353.
- ^ Kreidieh F (June 2, 2025). "Anemia: Practice Essentials, Pathophysiology, Etiology". Medscape. Retrieved May 4, 2025.
- ^ "Anemia | NHLBI, NIH". www.nhlbi.nih.gov. Retrieved February 8, 2022.
- ^ "Anemia – Symptoms and causes". Mayo Clinic. Retrieved April 1, 2022.
- ^ "Guideline on haemoglobin cutoffs to define anaemia in individuals and populations". World Health Organization. 2024. Archived from the original on January 1, 2026. Retrieved January 27, 2026.
- ^ National Institute for Care and Health Excellence (NICE) (October 2025). "Anaemia - iron deficiency". Clinical Knowledge Summaries. Retrieved December 23, 2025.
- ^ Rhodes CE, Denault D, Varacallo M (2024). "Physiology, Oxygen Transport". StatPearls. StatPearls Publishing. PMID 30855920.
- ^ Bhutta ZA, Das JK, Rizvi A, Gaffey MF, Walker N, Horton S, Webb P, Lartey A, Black RE (August 2013). "Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?". Lancet. 382 (9890): 452–477. Bibcode:2013Lanc..382..452B. doi:10.1016/S0140-6736(13)60996-4. PMID 23746776. S2CID 11748341.
- ^ a b Qaseem A, Humphrey LL, Fitterman N, Starkey M, Shekelle P (December 2013). "Treatment of anemia in patients with heart disease: a clinical practice guideline from the American College of Physicians". Annals of Internal Medicine. 159 (11): 770–779. doi:10.7326/0003-4819-159-11-201312030-00009. PMID 24297193. S2CID 4712203.
- ^ Vos T, et al. (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
- ^ Peyrin-Biroulet L, Williet N, Cacoub P (December 1, 2015). "Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review". The American Journal of Clinical Nutrition. 102 (6): 1585–1594. doi:10.3945/ajcn.114.103366. PMID 26561626.
- ^ a b Vos T, et al. (December 2012). "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2163–2196. doi:10.1016/S0140-6736(12)61729-2. PMC 6350784. PMID 23245607.
- ^ GBD 2013 Mortality Causes of Death Collaborators (January 2015). "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 385 (9963): 117–71. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442.
- ^ "WHO Global Anaemia estimates, 2021 Edition". World Health Organization. Retrieved February 27, 2022.
- ^ Islam MA (December 6, 2021). "Modeling the impact of campaign program on the prevalence of anemia in children under five: Anemia model". Journal of Mathematical Analysis and Modeling. 2 (3): 29–40. doi:10.48185/jmam.v2i3.362. ISSN 2709-5924.
- ^ FAO, IFAD, UNICEF, WFP, WHO (2025). The State of Food Security and Nutrition in the World 2025. FAO ; IFAD ; UNICEF ; WFP ; WHO. doi:10.4060/cd6008en. ISBN 978-92-5-139937-8.
- ^ "WHO | Interventions by global target". www.who.int. World Health Organization. Archived from the original on August 14, 2016.
- ^ "The case for action on anemia". Devex. June 14, 2016.
- ^ a b "Anemia Types, Treatment, Symptoms, Signs, Causes & Iron Deficiency". eMedicineHealth. Retrieved January 9, 2026.
- ^ "What Are Symptoms of Anemia?". National Heart, Lung, and Blood Institute. March 24, 2022. Retrieved June 26, 2022.
- ^ a b "Anemia". American Society of Hematology. Retrieved January 9, 2026.
- ^ "Anemia". Yale Medicine. Retrieved January 9, 2026.
- ^ a b Killeen RB, Kaur A, Afzal M (2026), "Acute Anemia", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 30725917, retrieved March 21, 2026
- ^ De Franceschi L, Iolascon A, Taher A, Cappellini MD (July 2017). "Clinical management of iron deficiency anemia in adults: Systemic review on advances in diagnosis and treatment". European Journal of Internal Medicine. 42: 16–23. doi:10.1016/j.ejim.2017.04.018. PMID 28528999.
- ^ Gallagher PG (August 11, 2022). "Anemia in the pediatric patient". Blood. 140 (6): 571–593. doi:10.1182/blood.2020006479. ISSN 0006-4971. PMC 9373018. PMID 35213686.
- ^ Ersianti YL, Susanah S, Winarno GN, Susiarno H, Herman H, Krisnadi SR (2026). "Analysis of Pallor Examination for the Identification of Anemia Among Pregnant Women: A Scoping Review". International Journal of Women's Health. 18: 1–12. doi:10.2147/IJWH.S550863. PMC 12983172. PMID 41835843.
- ^ a b "Anaemia". World Health Organization. February 10, 2025. Retrieved January 9, 2026.
- ^ "Identifying AEFI in diverse skin colour". The Melbourne Vaccine Education Centre (MVEC). Retrieved March 21, 2026.
- ^ "Iron deficiency anaemia symptoms and treatments". NHS inform. February 21, 2025. Retrieved March 27, 2026.
- ^ "Vitamin B12 or folate deficiency anaemia". National Health Service. February 20, 2023. Retrieved March 27, 2026.
- ^ Beutler E, Waalen J (March 2006). "The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?". Blood. 107 (5): 1747–1750. doi:10.1182/blood-2005-07-3046. PMC 1895695. PMID 16189263.
- ^ Anemia at eMedicine
- ^ Rodak BF (2007). Hematology: Clinical Principles and Applications (3rd ed.). Philadelphia: Saunders. p. 220. ISBN 978-1-4160-3006-5. Archived from the original on April 25, 2016.
- ^ Pomeranz AJ, Sabnis S, Busey S, Kliegman RM (2016). Pediatric Decision-Making Strategies (2nd ed.). Elsevier. ISBN 978-0-323-29854-4.
- ^ World Health Organization (2024). Guideline on haemoglobin cutoffs to define anaemia in individuals and populations. World Health Organization. p. xi. ISBN 978-92-4-008854-2. Retrieved December 23, 2025.
- ^ "anaemia". Dictionary.com. Archived from the original on July 14, 2014. Retrieved July 7, 2014.
- ^ Merck & Co. Occlusive Peripheral Arterial Disease, The Merck Manual Home Health Handbook website, revised and updated March 2010. Retrieved March 4, 2012.
- ^ "Chronic Limb-Threatening Ischemia (CLTI) – Vascular Cures". Archived from the original on October 29, 2021. Retrieved October 27, 2021.
- ^ Bellotto F, Cati A (March 2006). "Anemia ed ischemia miocardica: relazioni ed interferenze" [Anemia and myocardial ischemia: relationships and interferences]. Recenti Progressi in Medicina (in Italian). 97 (3): 153–164. doi:10.1701/121.1312. PMID 16700423.
- ^ Chhabra G (December 1, 2017). "Automated hematology analyzers: Recent trends and applications". Journal of Laboratory Physicians. 10 (1): 15–16. doi:10.4103/JLP.JLP_124_17. ISSN 0974-2727. PMC 5784285. PMID 29403197.
- ^ "Anemia". Radiologyinfo.org. Retrieved October 11, 2021.
- ^ Freeman AM, Zubair M (2026), "Anemia Screening", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 29763080, retrieved March 30, 2026
- ^ "Reticulocyte Count: Testing, Purpose & Results". Cleveland Clinic. Archived from the original on February 7, 2026. Retrieved March 30, 2026.
- ^ a b Freeman AM, Zubair M (2026), "Anemia Screening", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 29763080, retrieved March 30, 2026
- ^ Al Hadidi S (August 17, 2021). "Blood Smear: The Fifth Vital Sign in Hematology - Hematology.org". American Society of Hematology. Retrieved March 30, 2026.
- ^ "How should I assess a person with suspected malaria?". National Institute for Health and Care Excellence. January 2024. Retrieved March 30, 2026.
- ^ "Anaemia". National Kidney Federation. March 28, 2019. Retrieved March 30, 2026.
- ^ "Sickle Cell Disease". National Heart, Lung, and Blood Institute. July 22, 2022.
- ^ Dean L (2005), "Blood and the cells it contains", Blood Groups and Red Cell Antigens [Internet], National Center for Biotechnology Information (US), retrieved March 16, 2026
- ^ Higgins JM (March 2015). "Red blood cell population dynamics". Clinics in Laboratory Medicine. 35 (1): 43–57. doi:10.1016/j.cll.2014.10.002. PMC 4717490. PMID 25676371.
- ^ Lutz HU, Bogdanova A. Mechanisms tagging senescent red blood cells for clearance in healthy humans. Front Physiol. 2013;4:387
- ^ Föller M, Huber SM, Lang F (October 2008). "Erythrocyte programmed cell death". IUBMB Life. 60 (10): 661–668. doi:10.1002/iub.106. PMID 18720418. S2CID 41603762.
- ^ Lang F, Lang E, Föller M (October 2012). "Physiology and pathophysiology of eryptosis". Transfusion Medicine and Hemotherapy. 39 (5): 308–314. doi:10.1159/000342534. PMC 3678267. PMID 23801921.
- ^ Amilia A (December 2022). "Anaemia: Symptoms, causes and treatment | Bupa UK". www.bupa.co.uk. Retrieved March 19, 2026.
- ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa Table 12-1 in: Mitchell RS, Kumar V, Abbas AK, Fausto N (2007). Robbins Basic Pathology (8th ed.). Philadelphia: Saunders. ISBN 978-1-4160-2973-1.
- ^ Bhandari J, Thada PK, Killeen RB, Puckett Y (June 19, 2024), "Fanconi Anemia", StatPearls [Internet], StatPearls Publishing, PMID 32644559, retrieved January 8, 2026
- ^ Gregg XT, Prchal JT (2007). "Anemia of Endocrine Disorders". Williams Hermatology. McGraw-Hill.
- ^ Garcia-Prats JA (June 23, 2025). "Anemia of prematurity (AOP)". Uptodate Inc. Retrieved April 12, 2026.
- ^ a b "Anaemia". World Health Organization. February 10, 2025. Retrieved April 17, 2026.
- ^ "What Is Anemia?". National Heart, Lung, and Blood Institute (NHLBI). March 24, 2022. Archived from the original on June 13, 2022. Retrieved March 8, 2025.
- ^ a b "Causes and Risk Factors". National Heart, Lung, and Blood Institute (NHLBI). March 24, 2022. Retrieved March 8, 2025.
- ^ "Congenital dyserythropoietic anemia: MedlinePlus Genetics". National Library of Medicine. Retrieved October 8, 2025.
- ^ "Myelophthisic Anemia Workup: Approach Considerations, Leukoerythroblastic Picture, Histologic Findings". MedScape. January 10, 2022. Retrieved April 15, 2026.
- ^ Ganz T (August 2003). "Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation". Blood. 102 (3): 783–788. doi:10.1182/blood-2003-03-0672. PMID 12663437.
- ^ a b c d e f g h Dugdale M (June 1, 2001). "ANEMIA". Obstetrics and Gynecology Clinics of North America. 28 (2): 363–382. doi:10.1016/S0889-8545(05)70206-0. ISSN 0889-8545. PMID 11430182.
- ^ Randi ML, Bertozzi I, Santarossa C, Cosi E, Lucente F, Bogoni G, Biagetti G, Fabris F (March 30, 2020). "Prevalence and Causes of Anemia in Hospitalized Patients: Impact on Diseases Outcome". Journal of Clinical Medicine. 9 (4): 950. doi:10.3390/jcm9040950. ISSN 2077-0383. PMC 7230611. PMID 32235484.
- ^ a b Stein J, Connor S, Virgin G, Ong DE, Pereyra L (September 2016). "Anemia and iron deficiency in gastrointestinal and liver conditions". World Journal of Gastroenterology (Review). 22 (35): 7908–7925. doi:10.3748/wjg.v22.i35.7908. PMC 5028806. PMID 27672287.
- ^ Leffler DA, Green PH, Fasano A (October 2015). "Extraintestinal manifestations of coeliac disease". Nature Reviews Gastroenterology & Hepatology. 12 (10): 561–571. doi:10.1038/nrgastro.2015.131. PMID 26260366. S2CID 15561525.
- ^ Catassi C, Bai JC, Bonaz B, Bouma G, Calabrò A, Carroccio A, Castillejo G, Ciacci C, Cristofori F, Dolinsek J, Francavilla R, Elli L, Green P, Holtmeier W, Koehler P, Koletzko S, Meinhold C, Sanders D, Schumann M, Schuppan D, Ullrich R, Vécsei A, Volta U, Zevallos V, Sapone A, Fasano A (September 2013). "Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders". Nutrients (Review). 5 (10): 3839–3853. doi:10.3390/nu5103839. PMC 3820047. PMID 24077239.
- ^ Lomer MC (August 2011). "Dietary and nutritional considerations for inflammatory bowel disease". The Proceedings of the Nutrition Society (Review). 70 (3): 329–335. doi:10.1017/S0029665111000097. PMID 21450124.
- ^ Gerasimidis K, McGrogan P, Edwards CA (August 2011). "The aetiology and impact of malnutrition in paediatric inflammatory bowel disease". Journal of Human Nutrition and Dietetics (Review). 24 (4): 313–326. doi:10.1111/j.1365-277X.2011.01171.x. PMID 21564345.
- ^ Despotovic J, Mahoney D, Armsby C (2021). "Overview of hemolytic anemias in children". The Lecturio Medical Concept Library. UpToDate. Retrieved June 28, 2021.
- ^ Capriotti, Theresa, Frizzell, Joan Parker (2016). Pathophysiology: introductory concepts and clinical perspectives. Philadelphia: F.A. Davis Company. ISBN 978-0-8036-1571-7. OCLC 900626405.
- ^ Mitchell RS, Kumar V, Abbas AK, Fausto N (2007). Robbins Basic Pathology (8th ed.). Philadelphia: Saunders. p. 432. ISBN 978-1-4160-2973-1.
- ^ Zamora EA, Schaefer CA (2026), "Hereditary Spherocytosis", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 30969619, retrieved April 19, 2026
- ^ Junaid SZ, Patel K (2026), "Abetalipoproteinemia", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 30020727, retrieved April 19, 2026
- ^ Grace RF, Zanella A, Neufeld EJ, Morton DH, Eber S, Yaish H, Glader B (September 2015). "Erythrocyte pyruvate kinase deficiency: 2015 status report". American Journal of Hematology. 90 (9): 825–30. doi:10.1002/ajh.24088. PMC 5053227. PMID 26087744.
- ^ Frank JE (October 1, 2005). "Diagnosis and Management of G6PD Deficiency". American Family Physician. 72 (7): 1277–1282. ISSN 0002-838X. PMID 16225031.
- ^ Cotran RS, Kumar V, Fausto N, Robbins SL, Abbas AK (2005). Robbins and Cotran pathologic basis of disease. St. Louis, Mo: Elsevier Saunders. p. 637. ISBN 978-0-7216-0187-8.
- ^ "Autoimmune Hemolytic Anemia (AIHA)" By J.L. Jenkins. The Regional Cancer Center. 2001 Archived October 7, 2009, at the Wayback Machine
- ^ Berentsen S, Beiske K, Tjønnfjord GE (October 2007). "Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy". Hematology. 12 (5): 361–370. doi:10.1080/10245330701445392. PMC 2409172. PMID 17891600.
- ^ "Hemolytic Anemia". Johns Hopkins Medicine. Retrieved April 19, 2026.
- ^ Köhne I (September 2020). "Haemolysis induced by mechanical circulatory support devices: unsolved problems". Perfusion. 35 (6): 474–483. doi:10.1177/0267659120931307. ISSN 1477-111X. PMC 7416332. PMID 32571178.
- ^ Stijlemans B, Guilliams M, Raes G, Beschin A, Magez S, De Baetselier P (August 2007). "African trypanosomosis: From immune escape and immunopathology to immune intervention". Veterinary Parasitology. 148 (1): 3–13. doi:10.1016/j.vetpar.2007.05.005. PMID 17560035.
- ^ Herman TF, Killeen RB, Javaid MU (June 8, 2023), "Heinz Body", StatPearls [Internet], StatPearls Publishing, PMID 31869086, retrieved April 7, 2026
- ^ "Do Hemorrhoids Cause Iron Deficiency Anemia?". June 26, 2018.
- ^ Brooker S, Hotez PJ, Bundy DA (September 2008). "Hookworm-related anaemia among pregnant women: a systematic review". PLOS Neglected Tropical Diseases. 2 (9) e291. Bibcode:2008PNTDi...2..291B. doi:10.1371/journal.pntd.0000291. PMC 2553481. PMID 18820740.
- ^ Gyorkos TW, Gilbert NL, Larocque R, Casapía M (April 2011). "Trichuris and hookworm infections associated with anaemia during pregnancy". Tropical Medicine & International Health. 16 (4): 531–537. doi:10.1111/j.1365-3156.2011.02727.x. PMID 21281406. S2CID 205391965.
- ^ Erdik B (May 7, 2023). "Anemia From Period: Symptoms, Treatment, And Complications". HealthMatch. Retrieved April 12, 2026.
- ^ a b "Is Anemia a Sign of Cancer?". The American Cancer Society. February 26, 2025. Retrieved April 12, 2026.
- ^ Whitehead NS, Williams LO, Meleth S, Kennedy SM, Ubaka-Blackmoore N, Geaghan SM, Nichols JH, Carroll P, McEvoy MT, Gayken J, Ernst DJ, Litwin C, Epner P, Taylor J, Graber ML (December 2019). "Interventions to prevent iatrogenic anemia: a Laboratory Medicine Best Practices systematic review". Critical Care. 23 (1): 278. doi:10.1186/s13054-019-2511-9. PMC 6688222. PMID 31399052.
- ^ Martin ND, Scantling D (September 2015). "Hospital-Acquired Anemia: A Contemporary Review of Etiologies and Prevention Strategies". Journal of Infusion Nursing. 38 (5): 330–338. doi:10.1097/NAN.0000000000000121. PMID 26339939. S2CID 30859103.
- ^ Hung SC, Kuo KL, Peng CH, Wu CH, Wang YC, Tarng DC (2015). "Association of Fluid Retention With Anemia and Clinical Outcomes Among Patients With Chronic Kidney Disease". Journal of the American Heart Association. 4 (1) e001480. doi:10.1161/JAHA.114.001480. PMC 4330071. PMID 25559015.
- ^ "Fluid imbalances". Portable Fluids and Electrolytes (Portable Series). Hagerstwon, MD: Lippincott Williams & Wilkins. 2007. p. 62. ISBN 978-1-58255-678-9.
- ^ "ISBT: 8. Obstetric anaemia". www.isbtweb.org. Retrieved May 22, 2018.
- ^ a b c d e Turner J, Parsi M, Badireddy M (August 8, 2023), "Anemia", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 29763170, retrieved April 1, 2026
- ^ "What Is Microcytic Anemia?". Cleveland Clinic. June 2024. Archived from the original on March 3, 2026. Retrieved April 2, 2026.
- ^ "What Is Normocytic Anemia?". Cleveland Clinic. October 2022. Retrieved April 2, 2026.
- ^ "Hemolytic Anemia | Symptoms, Diagnosis & Treatment". www.cincinnatichildrens.org. Retrieved April 6, 2026.
- ^ "Glucose-6-phosphate dehydrogenase deficiency: MedlinePlus Genetics". National Library of Medicine. Retrieved April 6, 2026.
- ^ Killeen RB, Kaur A, Afzal M (February 26, 2025), "Acute Anemia", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 30725917, retrieved April 6, 2026
- ^ Gale RP, Barosi G, Barbui T, Cervantes F, Dohner K, Dupriez B, et al. (January 2011). "What are RBC-transfusion-dependence and -independence?". Leukemia Research. 35 (1): 8–11. doi:10.1016/j.leukres.2010.07.015. PMC 8215731. PMID 20692036.
- ^ a b Melchert M, List AF (2007). "Management of RBC-transfusion dependence". Hematology. American Society of Hematology. Education Program. 2007: 398–404. doi:10.1182/asheducation-2007.1.398. PMID 18024657.
- ^ Hillyer CD, Silberstein LE, Ness PM, Anderson KC, Roback JD (2006). Blood Banking and Transfusion Medicine: Basic Principles and Practice. Elsevier Health Sciences. p. 534. ISBN 978-0-7020-3625-5.
- ^ Mandel J, Taichman D (2006). Pulmonary Vascular Disease. Elsevier Health Sciences. p. 170. ISBN 978-1-4160-2246-6.
- ^ Ferri FF (2015). BOPOD – Ferri's Clinical Advisor 2016. Elsevier Health Sciences. p. 1131.e2. ISBN 978-0-323-37822-2.
- ^ "Anemia – Symptoms and causes". Mayo Clinic. May 11, 2023. Retrieved April 1, 2022.
- ^ Killeen RB, Kaur A, Afzal M (2026), "Acute Anemia", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 30725917, retrieved April 21, 2026
- ^ a b "Anaemia: Symptoms, causes and treatment | Bupa UK". www.bupa.co.uk. Retrieved April 20, 2026.
- ^ a b "Iron deficiency anaemia". National Health Service. January 26, 2024. Retrieved April 21, 2026.
- ^ "Understanding Hookworm | UMass Memorial Health". www.ummhealth.org. Retrieved April 24, 2026.
- ^ a b "Anemia". Cleveland Clinic. April 16, 2024.
- ^ Bolton-Maggs PH, Stevens RF, Dodd NJ, Lamont G, Tittensor P, King MJ, General Haematology Task Force of the British Committee for Standards in Haematology (2004). "Guidelines for the diagnosis and management of hereditary spherocytosis". British Journal of Haematology. 126 (4): 455–474. doi:10.1111/j.1365-2141.2004.05052.x. PMID 15287938. S2CID 5870305.
- ^ Frank JE (October 1, 2005). "Diagnosis and Management of G6PD Deficiency". American Family Physician. 72 (7): 1277–1282. ISSN 0002-838X. PMID 16225031.
- ^ Lucarelli G, Isgrò A, Sodani P, Gaziev J (May 1, 2012). "Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Anemia". Cold Spring Harbor Perspectives in Medicine. 2 (5) a011825. doi:10.1101/cshperspect.a011825. ISSN 2157-1422. PMC 3331690. PMID 22553502.
- ^ Martin ND, Scantling D (2015). "Hospital-Acquired Anemia". Journal of Infusion Nursing. 38 (5): 330–338. doi:10.1097/NAN.0000000000000121. ISSN 1533-1458. PMID 26339939. S2CID 30859103.
- ^ Eaton KP, Levy K, Soong C, Pahwa AK, Petrilli C, Ziemba JB, Cho HJ, Alban R, Blanck JF, Parsons AS (2017). "Evidence-Based Guidelines to Eliminate Repetitive Laboratory Testing". JAMA Internal Medicine. 177 (12): 1833–1839. doi:10.1001/jamainternmed.2017.5152. ISSN 2168-6106. PMID 29049500. S2CID 40475834.
- ^ Rodgers GM, Becker PS, Bennett CL, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Djulbegovic B, Garst JL, Gilreath JA, Kraut EH, Lin WC, Matulonis U, Millenson M, Reinke D, Rosenthal J, Sabbatini P, Schwartz RN, Stein RS, Vij R (July 2008). "Cancer- and chemotherapy-induced anemia". Journal of the National Comprehensive Cancer Network. 6 (6): 536–64. doi:10.6004/jnccn.2008.0042. PMID 18597709.
- ^ a b c Nguyen M, Tadi P (2026), "Iron Supplementation", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32491308, retrieved April 23, 2026
- ^ "Blood Transfusion". National Heart, Lung, and Blood Institute (NHLBI). Archived from the original on June 23, 2019. Retrieved June 16, 2019.
- ^ Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N, Fergusson DA, et al. (December 2021). "Transfusion thresholds for guiding red blood cell transfusion". The Cochrane Database of Systematic Reviews. 12 (12) CD002042. doi:10.1002/14651858.CD002042.pub5. PMC 8691808. PMID 34932836.
- ^ a b "Treatments for Blood Disorders - Treatments for Blood Disorders | NHLBI, NIH". www.nhlbi.nih.gov. March 24, 2022. Retrieved April 28, 2026.
- ^ Johns Hopkins Medicine. (n.d.). Aplastic anemia. The Johns Hopkins University & Health System. Retrieved October 19, 2025 https://www.hopkinsmedicine.org/kimmel-cancer-center/cancers-we-treat/blood-bone-marrow-cancers/aplastic-anemia
- ^ "What Is Pernicious Anemia?". National Heart, Lung, and Blood Institute. April 1, 2011. Archived from the original on March 14, 2016. Retrieved March 14, 2016.
- ^ Langan RC, Goodbred AJ (September 15, 2017). "Vitamin B12 Deficiency: Recognition and Management". American Family Physician. 96 (6): 384–389. PMID 28925645.
- ^ "Pernicious Anemia Clinical Presentation: History, Physical Examination". September 14, 2017. Archived from the original on September 14, 2017. Retrieved August 4, 2022.
- ^ Schoener, Benjamin; Borger, Judith (2025), "Erythropoietin Stimulating Agents", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 30725682, retrieved 2025-10-19
- ^ "Information on Erythropoiesis-Stimulating Agents (ESA) Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp)". US Food and Drug Administration – Drug Safety Information. March 31, 2017. Archived from the original on April 14, 2022.
- ^ a b Banzi R, Gerardi C (December 23, 2016). WHO EML 2016-2017 - Application for erythropoietin-stimulating agents (erythropoietin type blood factors) (PDF) (Report). WHO. WHO EML 2016–2017, Version 3. Archived from the original (PDF) on August 31, 2020.
- ^ Gardner WM, Razo C, McHugh TA, Hagins H, Vilchis-Tella VM, Hennessy C, Taylor HJ, Perumal N, Fuller K, Cercy KM, Zoeckler LZ, Chen CS, Lim SS, Aali A, Abate KH (2023). "Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021". The Lancet Haematology. 10 (9): e713–e734. doi:10.1016/S2352-3026(23)00160-6. ISSN 2352-3026. PMC 10465717. PMID 37536353.
- ^ a b "The Lancet: New study reveals global anemia cases remain persistently high among women and children. Anemia rates decline for men. | Institute for Health Metrics and Evaluation". www.healthdata.org. July 31, 2023. Retrieved May 18, 2026.
- ^ Walter AW (November 2024). "Perinatal Anemia - Pediatrics". MSD Manual Professional Edition. Retrieved May 19, 2026.
- ^ Ziegler EE (November 2011). "Consumption of cow's milk as a cause of iron deficiency in infants and toddlers: Nutrition Reviews©, Vol. 69, No. S1". Nutrition Reviews. 69: S37–S42. doi:10.1111/j.1753-4887.2011.00431.x.
- ^ "Iron deficiency in children: Prevention tips for parents". Mayo Clinic. February 2024. Retrieved May 19, 2026.
- ^ Obeagu GU, Obeagu EI (August 29, 2025). "Complications of anemia in pregnancy: An updated overview for healthcare professionals". Medicine. 104 (35). doi:10.1097/MD.0000000000044246. ISSN 1536-5964. PMC 12401385. PMID 40898523.
- ^ American College of Obstetricians Gynecologists' Committee on Practice Bulletins—Obstetrics (August 2021). "Anemia in Pregnancy: ACOG Practice Bulletin, Number 233". Obstetrics & Gynecology. 138 (2): e55–e64. doi:10.1097/AOG.0000000000004477. ISSN 0029-7844. PMID 34293770. S2CID 236198933.
- ^ "Iron Deficiency Anaemia in pregnancy and after birth". Digital patient information hub of Bradford Teaching Hospitals. May 2024. Retrieved May 19, 2026.
- ^ Kattamis A, Forni GL, Aydinok Y, Viprakasit V (December 2020). "Changing patterns in the epidemiology of β-thalassemia". European Journal of Haematology. 105 (6): 692–703. doi:10.1111/ejh.13512. PMC 7692954. PMID 32886826.
- ^ Williams TN, Weatherall DJ (September 2012). "World distribution, population genetics, and health burden of the hemoglobinopathies". Cold Spring Harbor Perspectives in Medicine. 2 (9) a011692. doi:10.1101/cshperspect.a011692. PMC 3426822. PMID 22951448.
- ^ "Anaemia". www.who.int. Retrieved May 21, 2026.
- ^ Ritchie H (November 25, 2024). "Billions of people suffer from anemia, but there are cheap ways to reduce this". Our World in Data.
- ^ Smith M, Drakesmith CW, Haynes S, Maynard S, Shah A, Roy NB, Lee JJ, Maurer K, Stanworth SJ, Bankhead CR (April 1, 2025). "Prevalence and patterns of testing for anaemia in primary care in England: a cohort study using an electronic health records database". British Journal of General Practice. 75 (753): e232–e240. doi:10.3399/BJGP.2024.0336. ISSN 0960-1643. PMC 11881008. PMID 39658076.
- ^ Williams AM, Ansai N, Ahluwalia N, Nguyen DT (December 2024), "Anemia Prevalence: United States, August 2021–August 2023", NCHS Data Briefs [Internet], National Center for Health Statistics (US), PMID 40048464, retrieved May 21, 2026
- ^ Tayles N (September 1996). "Anemia, genetic diseases, and malaria in prehistoric mainland Southeast Asia". American Journal of Physical Anthropology. 101 (1): 11–27. doi:10.1002/(SICI)1096-8644(199609)101:1<11::AID-AJPA2>3.0.CO;2-G. PMID 8876811.
- ^ a b Sheftel AD, Mason AB, Ponka P (March 2012). "The long history of iron in the Universe and in health and disease". Biochimica et Biophysica Acta (BBA) - General Subjects. 1820 (3): 161–187. Bibcode:2012BBAcG1820..161S. doi:10.1016/j.bbagen.2011.08.002. ISSN 0006-3002. PMC 3258305. PMID 21856378.
- ^ a b Aird W (May 12, 2022). "Did you know that anemia was first named as a clinical entity in 1807? • The Blood Project". The Blood Project. Retrieved November 30, 2025.
- ^ Hens SM, Godde K, Macak KM (March 7, 2019). "Iron deficiency anemia, population health and frailty in a modern Portuguese skeletal sample". PLOS ONE. 14 (3) e0213369. Bibcode:2019PLoSO..1413369H. doi:10.1371/journal.pone.0213369. ISSN 1932-6203. PMC 6405098. PMID 30845224.